Overweight or obese people with early multiple sclerosis (MS) exhibit subtle gait changes, including taking wider steps.

People with MS who closely follow a healthy diet had better disability scores over one year than those with lower adherence, ...

A review study found resistance training, Pilates, and HIIT were linked to lower levels of the nerve damage biomarker NfL in ...

Daily propionic acid supplements lowered levels of a nerve damage marker in people with MS, but clinical benefits remain ...

A noninvasive brain stimulation technique may help adults with multiple sclerosis walk farther and improve their balance.

Columnist Ben Hofmeister has taken the liberty of adapting a few notorious quotes from the blockbuster film "Aliens" and applying them to MS.

Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.

Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.

AB Science has discontinued a large, late-stage trial testing its oral therapy masitinib in people with progressive multiple sclerosis. The trial was stopped due to a change in company priorities, not ...

Difficulties finding the right words during speech affect 25% of MS patients, and often occur alongside broader cognitive ...

What is remibrutinib for MS? Remibrutinib, also called LOU064, is an experimental oral medicine being evaluated as a means to reduce inflammation in relapsing forms of multiple sclerosis (MS).